insolvency and infringement of intellectual property rights, Numico may
terminate the agreement as of December 31, 2011, provided that Numico
has given six months prior written notice. Along with other supply
agreements entered into over the last two years, Martek now has sole
source commitments through at least 2011 with customers that comprise
more than 70% of current infant formula revenues.
-- New Infant Formula Licensee -- In December 2007, Martek announced that
it had entered into a multi-year license and supply agreement with Il
Dong Foods for the inclusion of Martek's DHA and ARA in infant formula
sold in South Korea.
-- New Data Published on Benefits of DHA -- The benefits of DHA
supplementation were recently discussed in several publications:
-- A pre-clinical study published in the Journal of Neuroscience
(December 2007) reported that DHA was found to decrease an important
risk factor for late-onset Alzheimer's disease. Conducted at the
University of California, Los Angeles using a mouse model, a
diabetic rat model and cultured human cells, the study found that
DHA increases the production of LR11, a protein vital to clearing
the brain of the enzymes that make the beta amyloid plaques that are
thought to cause Alzheimer's disease. The investigators used
Martek's life'sDHA(TM) for a portion of the research.
-- A study published in the Journal of Nutrition (January 2008)
demonstrated the effects of DHA supplementation on remnant-like
particle-cholesterol (RLP-C) and red blood cell omega-3 content in
plasma, two potential risk factors for cardiovascular disease. In
the study, 28 hypertriglyceridemic men were given 3 grams of DHA per
day or an oliv
|SOURCE Martek Biosciences Corporation|
Copyright©2008 PR Newswire.
All rights reserved